The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism



      To investigate if the immunomodulator drug DINAC (1) affects arterial dimensions in asymptomatic patients with hypercholesterolemia, (2) has effects on leucocyte markers of inflammation and (3) has in vitro effects on nitric oxide synthase (NOS) in human umbilical vein endothelial cells (HUVEC).

      Methods and results

      One hundred and fifty-three patients with asymptomatic hypercholesterolemia were randomized to either 100 or 500 mg of DINAC or placebo in a double-blind, parallel-group fashion for 24 weeks. Treatment at the highest dose induced a significant increase in resting brachial artery diameter measured by ultrasound and also induced a significant increase in vessel diameter during hyperemia. However, flow-mediated vasodilation (FMD) and the vasodilatory response to nitroglycerin, lipid levels or leukocyte count were unaltered. Expression of several cell surface markers of inflammation, like CD11b and CD25, were reduced by treatment. In vitro, DINAC counteracted TNF-α induced reductions in NO levels and in NOS protein and mRNA levels.


      The immunomodulator drug DINAC increased brachial artery diameter at rest and during hyperemia in asymptomatic subjects with hypercholesterolemia without affecting blood lipid levels. Based on parallel in vitro studies this effect is likely due to an enhancement of NOS activity.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Landmesser U.
        • Hornig B.
        • Drexler H.
        Endothelial function: a critical determinant in atherosclerosis?.
        Circulation. 2004; 109: II27-II33
        • Sharma N.
        • Rutherford J.D.
        • Grayston J.T.
        • et al.
        Association between C-reactive protein, anti-Chlamydia pneumoniae antibodies, and vascular function in healthy adults.
        Am J Cardiol. 2001; 87 (A9): 119-121
        • Raza K.
        • Thambyrajah J.
        • Townend J.N.
        • et al.
        Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?.
        Circulation (Online). 2000; 102: 1470-1472
        • Hingorani A.D.
        • Cross J.
        • Kharbanda R.K.
        • et al.
        Acute systemic inflammation impairs endothelium-dependent dilatation in humans.
        Circulation. 2000; 102: 994-999
        • Gokce N.
        • Keaney Jr., J.F.
        • Hunter L.M.
        • et al.
        Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study.
        Circulation. 2002; 105: 1567-1572
        • Heitzer T.
        • Schlinzig T.
        • Krohn K.
        • Meinertz T.
        • Munzel T.
        Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.
        Circulation. 2001; 104: 2673-2678
        • Halcox J.P.
        • Schenke W.H.
        • Zalos G.
        • et al.
        Prognostic value of coronary vascular endothelial dysfunction.
        Circulation. 2002; 106: 653-658
        • Perticone F.
        • Ceravolo R.
        • Pujia A.
        • et al.
        Prognostic significance of endothelial dysfunction in hypertensive patients.
        Circulation. 2001; 104: 191-196
        • Schachinger V.
        • Britten M.B.
        • Zeiher A.M.
        Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.
        Circulation. 2000; 101: 1899-1906
        • Suwaidi J.A.
        • Hamasaki S.
        • Higano S.T.
        • et al.
        Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.
        Circulation. 2000; 101: 948-954
        • Libby P.
        • Ridker P.M.
        • Maseri A.
        Inflammation and atherosclerosis.
        Circulation. 2002; 105: 1135-1143
        • Ross R.
        The pathogenesis of atherosclerosis: a perspective for the 1990s.
        Nature. 1993; 362: 801-809
        • Ridker P.M.
        • Rifai N.
        • Stampfer M.J.
        • Hennekens C.H.
        Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.
        Circulation. 2000; 101: 1767-1772
        • Rohde L.E.
        • Lee R.T.
        • Rivero J.
        • et al.
        Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis..
        Arterioscl Thromb Vasc Biol. 1998; 18: 1765-1770
        • Ridker P.M.
        • Glynn R.J.
        • Hennekens C.H.
        C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction [comment].
        Circulation. 1998; 97: 2007-2011
        • Sarnstrand B.
        • Jansson A.H.
        • Matuseviciene G.
        • et al.
        N,N′-Diacetyl-l-cystine – the disulfide dimer of N-acetylcysteine – is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents.
        J Pharmacol Exp Therap. 1999; 288: 1174-1184
        • Hiestand P.C.
        • Strasser M.
        Immunomodulating activities of ethylene-2,2′-bis(dithio)bis(ethanol) and related compounds. Effects on murine lymphocyte proliferation and functions in vitro.
        Int J Immunopharmacol. 1985; 7: 129-140
        • Droge W.
        • Schulze-Osthoff K.
        • Mihm S.
        • et al.
        Functions of glutathione and glutathione disulfide in immunology and immunopathology.
        FASEB J. 1994; 8: 1131-1138
        • Jeannin P.
        • Delneste Y.
        • Lecoanet-Henchoz S.
        • et al.
        Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis.
        J Exp Med. 1995; 182: 1785-1792
        • St Georgiev V.
        New synthetic immunomodulating agents.
        Trends Pharmacol Sci. 1988; 9: 446-451
        • Askenase P.W.
        Delayed-type hypersensitivity recruitment of T cell subsets via antigen-specific non-IgE factors or IgE antibodies: relevance to asthma, autoimmunity and immune responses to tumors and parasites.
        Chem Immunol. 1992; 54: 166-211
        • Wagberg M.
        • Jansson A.H.
        • Westerlund C.
        • et al.
        N,N′-Diacetyl-l-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis.
        J Pharmacol Exp Therap. 2001; 299: 76-82
        • Anderson T.J.
        • Meredith I.T.
        • Yeung A.C.
        • et al.
        The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.
        New Engl J Med. 1995; 332: 488-493
        • Zapolska-Downar D.
        • Zapolski-Downar A.
        • Markiewski M.
        • et al.
        Selective inhibition by probucol of vascular cell adhesion molecule-1 (VCAM-1) expression in human vascular endothelial cells.
        Atherosclerosis. 2001; 155: 123-130
        • Jiang J.L.
        • Li N.S.
        • Li Y.J.
        • Deng H.W.
        Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
        Br J Pharmacol. 2002; 135: 1175-1182
        • Inoue N.
        • Ohara Y.
        • Fukai T.
        • Harrison D.G.
        • Nishida K.
        Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits.
        Am J Med Sci. 1998; 315: 242-247
        • Keaney Jr., J.F.
        • Xu A.
        • Cunningham D.
        • et al.
        Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
        J Clin Invest. 1995; 95: 2520-2529
        • Witting P.
        • Pettersson K.
        • Ostlund-Lindqvist A.M.
        • et al.
        Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits [see comments].
        J Clin Invest. 1999; 104: 213-220
        • Witting P.K.
        • Pettersson K.
        • Letters J.
        • Stocker R.
        Site-specific anti-atherogenic effect of probucol in apolipoprotein E deficient mice.
        Arterioscl Thromb Vasc Biol. 2000; 20: e26-e33
        • Brandt-Eliasson U.
        • Abrahamsson T.
        • Walldius G.
        • Pettersson K.
        N,N′-Diacetyl-l-cystine (DiNAC) improves endothelial vasodilatory function in WHHL rabbits.
        Atherosclerosis. 2000; 151: 210-211
        • Cooke J.P.
        • Dzau V.J.
        Nitric oxide synthase: role in the genesis of vascular disease.
        Annu Rev Med. 1997; 48: 489-509
        • Ludmer P.L.
        • Selwyn A.P.
        • Shook T.L.
        • et al.
        Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.
        New Engl J Med. 1986; 315: 1046-1051
        • Sorensen K.E.
        • Celermajer D.S.
        • Spiegelhalter D.J.
        • et al.
        Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.
        Br Heart J. 1995; 74: 247-253
        • Mullen M.J.
        • Kharbanda R.K.
        • Cross J.
        • et al.
        Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia.
        Circ Res. 2001; 88: 145-151
        • Kuvin J.T.
        • Patel A.R.
        • Sliney K.A.
        • et al.
        Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease.
        J Am Coll Cardiol. 2001; 38: 1843-1849
        • Lenkei R.
        • Andersson B.
        High correlations of anti-CMV titers with lymphocyte activation status and CD57 antibody-binding capacity as estimated with three-color, quantitative flow cytometry in blood donors.
        Clin Immunol Immunopathol. 1995; 77: 131-138
        • Kinlay S.
        • Creager M.A.
        • Fukumoto M.
        • et al.
        Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo.
        Hypertension. 2001; 38: 1049-1053
        • Lind L.
        • Sarabi M.
        • Millgard J.
        Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm.
        Clin Physiol. 1998; 18: 81-87
        • Booth A.D.
        • Jayne D.R.
        • Kharbanda R.K.
        • et al.
        Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
        Circulation. 2004; 109: 1718-1723
        • Bhagat K.
        • Moss R.
        • Collier J.
        • Vallance P.
        Endothelial “stunning” following a brief exposure to endotoxin: a mechanism to link infection and infarction?.
        Cardiovasc Res. 1996; 32: 822-829
        • Ridker P.M.
        • Cannon C.P.
        • Morrow D.
        • et al.
        C-reactive protein levels and outcomes after statin therapy.
        N Engl J Med. 2005; 352: 20-28
        • Berliner S.
        • Rogowski O.
        • Rotstein R.
        • et al.
        Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis.
        Cardiology. 2000; 94: 19-25
        • Kassirer M.
        • Zeltser D.
        • Prochorov V.
        • et al.
        Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: further evidence for smoldering inflammation in patients with atherosclerosis.
        Am Heart J. 1999; 138: 555-559
        • Mazzone A.
        • De Servi S.
        • Mazzucchelli I.
        • et al.
        Increased expression of CD11b/CD18 on phagocytes in ischaemic disease: a bridge between inflammation and coagulation.
        Eur J Clin Invest. 1997; 27: 648-652
        • Stemme S.
        • Holm J.
        • Hansson G.K.
        T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1.
        Arterioscler Thromb. 1992; 12: 206-211
        • Neri Serneri G.G.
        • Prisco D.
        • Martini F.
        • et al.
        Acute T-cell activation is detectable in unstable angina.
        Circulation. 1997; 95: 1806-1812
        • Mullen M.J.
        • Kharbanda R.K.
        • Cross J.
        • et al.
        Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia.
        Circ Res. 2001; 88: 145-151